Bambusa Stock and Aspen Stock Fall in Nasdaq IPO Debuts
Friday, 30 October 2026, 17:05
Bambusa and Aspen Shares Drop After IPOs
Bambusa Therapeutics (BBTX) and Aspen Neuroscience (ASPE) fell in their Nasdaq debuts after raising $168.9 million and $140.6 million, respectively. Together, the companies secured $309.5 million in IPO proceeds.
Key IPO Details
- Bambusa Therapeutics (BBTX): raised $168.9 million; its stock declined in its Nasdaq debut.
- Aspen Neuroscience (ASPE): raised $140.6 million; its stock also fell after listing.
The initial share-price moves show that strong fundraising totals do not ensure gains on the first day of trading. For additional details, consult the original report.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.